About LatchBio
Latch.bio offers a cloud-based platform for biotech companies to manage and analyze their data. It allows users to store unlimited raw data, facilitating collaboration and quick decision-making through an easy-to-use interface. The platform is customizable, reducing infrastructure setup time and costs while ensuring data security. Latch.bio's goal is to accelerate research and development milestones by providing a comprehensive and cost-effective data solution.
San Francisco, CaliforniaHeadquarters
2021Year Founded
$32.1MTotal Funding
SERIES_ACompany Stage
Data & Analytics, BiotechnologyIndustries
11-50Employees
Benefits
Competitive salary
Equity
Medical, dental, & vision insurance
Risks
Competition from DNAnexus and Seven Bridges may erode LatchBio's market share.
Rapid tech advancements require constant updates, straining LatchBio's resources and profitability.
Reliance on GPU technology exposes LatchBio to supply chain issues and price fluctuations.
Differentiation
LatchBio offers a code-free platform, simplifying data analysis for non-specialists.
The platform provides unlimited data storage, eliminating silos and enhancing collaboration.
LatchBio's customizable platform allows biotech firms control over data without infrastructure setup costs.
Upsides
Increased adoption of cloud-native technologies boosts demand for LatchBio's scalable solutions.
The rise of personalized medicine aligns with LatchBio's robust data analysis capabilities.
AI integration in drug discovery creates opportunities for LatchBio's supportive infrastructure.
Funding
Total raised$32.10 M
Latest valuation$140.00 M
StageSERIES_A
SERIES A
5/31/2022$28
$140.00 M$5
$25.00 M